Adding tilsotolimod to ipilimumab did not improve response or survival outcomes in patients with advanced melanoma.

Georgina V. Long, MD, MSc, discussed the long-term follow-up data for the combination of adjuvant dabrafenib and trametinib ...

Early detection of melanoma through mole checks can significantly increase survival rates. Dermatologists use the ABCDE rule ...

During a live event, Thach-Giao Truong, MD, moderated a discussion on treating a 78-year-old patient with metastatic melanoma ...

Gestalt's PathFlow is known for its versatility, supporting primary diagnoses*, education, resident training, and research workflows. By integrating Primaa's advanced AI algorithms, the platform now ...

PORTLAND, OR, UNITED STATES, March 20, 2025 /EINPresswire / -- The global skin cancer treatment market has exp ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

Phase III DIPPER trial shows that adjuvant camrelizumab administered after induction-concurrent chemoradiotherapy ...

While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing ...

Windows are indispensable for bringing natural light, ventilation, and aesthetic appeal to buildings. However, their inherent ...

A world where a robot quickly scans your body for skin cancer or your forehead lines stay frozen with just a treatment or two ...

The Exosome Therapeutics Market is projected to grow from $30 million in 2029 to $1.4 billion by 2040, at a CAGR of 41.1%.